251 related articles for article (PubMed ID: 34568981)
1. Iron replacement therapy in heart failure: a literature review.
Ismahel H; Ismahel N
Egypt Heart J; 2021 Sep; 73(1):85. PubMed ID: 34568981
[TBL] [Abstract][Full Text] [Related]
2. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype.
Fitzsimons S; Yeo TJ; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Poppe K; Lund M; Devlin G; Troughton R; Lam CSP; Richards AM; Doughty RN
ESC Heart Fail; 2021 Dec; 8(6):4572-4583. PubMed ID: 34592056
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ferric Carboxymaltose Supplementation in Patients with Heart Failure with Preserved Ejection Fraction: Role of Attenuated Oxidative Stress and Improved Endothelial Function.
Mollace A; Macrì R; Mollace R; Tavernese A; Gliozzi M; Musolino V; Carresi C; Maiuolo J; Nicita M; Caminiti R; Paone S; Barillà F; Volterrani M; Mollace V
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501086
[TBL] [Abstract][Full Text] [Related]
4. Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction.
Martens P; Nijst P; Verbrugge FH; Smeets K; Dupont M; Mullens W
Acta Cardiol; 2018 Apr; 73(2):115-123. PubMed ID: 28730869
[TBL] [Abstract][Full Text] [Related]
5. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
Ebner N; Jankowska EA; Ponikowski P; Lainscak M; Elsner S; Sliziuk V; Steinbeck L; Kube J; Bekfani T; Scherbakov N; Valentova M; Sandek A; Doehner W; Springer J; Anker SD; von Haehling S
Int J Cardiol; 2016 Feb; 205():6-12. PubMed ID: 26705670
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials.
Zhang J; Hu S; Jiang Y; Zhou Y
Postgrad Med J; 2020 Dec; 96(1142):766-776. PubMed ID: 32843482
[TBL] [Abstract][Full Text] [Related]
7. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.
López-Vilella R; Lozano-Edo S; Arenas Martín P; Jover-Pastor P; Ezzitouny M; Sorolla Romero J; Calvo Asensio M; Martínez-Solé J; Guerrero Cervera B; Sánchez Martínez JC; Donoso Trenado V; Sánchez-Lázaro I; Martinez Dolz L; Almenar Bonet L
ESC Heart Fail; 2022 Feb; 9(1):133-145. PubMed ID: 34964300
[TBL] [Abstract][Full Text] [Related]
8. Anaemia, iron deficiency and heart failure in 2020: facts and numbers.
Chopra VK; Anker SD
ESC Heart Fail; 2020 Oct; 7(5):2007-2011. PubMed ID: 32602663
[TBL] [Abstract][Full Text] [Related]
9. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
Bekfani T; Pellicori P; Morris D; Ebner N; Valentova M; Sandek A; Doehner W; Cleland JG; Lainscak M; Schulze PC; Anker SD; von Haehling S
Clin Res Cardiol; 2019 Feb; 108(2):203-211. PubMed ID: 30051186
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency.
Ponikowski P; van Veldhuisen DJ; Comin-Colet J; Ertl G; Komajda M; Mareev V; McDonagh TA; Parkhomenko A; Tavazzi L; Levesque V; Mori C; Roubert B; Filippatos G; Ruschitzka F; Anker SD
ESC Heart Fail; 2014 Sep; 1(1):52-58. PubMed ID: 28834668
[TBL] [Abstract][Full Text] [Related]
11. Treating Iron Deficiency (ID) Anemia in Heart Failure (HF) Patients with IV Iron: A Meta-Analysis.
Ogugua FM; Aguilar FA; Gamam A; Maqsood MH; Yoo TK; Kasmi F; AlKowatli O; Lo K
Cureus; 2023 Jul; 15(7):e41895. PubMed ID: 37581143
[TBL] [Abstract][Full Text] [Related]
12. Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry.
Becher PM; Schrage B; Benson L; Fudim M; Corovic Cabrera C; Dahlström U; Rosano GMC; Jankowska EA; Anker SD; Lund LH; Savarese G
Eur J Heart Fail; 2021 Nov; 23(11):1844-1854. PubMed ID: 34476878
[TBL] [Abstract][Full Text] [Related]
13. Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
Sindone A; Doehner W; Manito N; McDonagh T; Cohen-Solal A; Damy T; Núñez J; Pfister O; van der Meer P; Comin-Colet J
J Clin Med; 2022 May; 11(11):. PubMed ID: 35683366
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis.
Anker SD; Khan MS; Butler J; von Haehling S; Jankowska EA; Ponikowski P; Friede T
Eur J Heart Fail; 2023 Jul; 25(7):1080-1090. PubMed ID: 37062867
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency.
Sindone A; Doehner W; Comin-Colet J
ESC Heart Fail; 2023 Feb; 10(1):44-56. PubMed ID: 36178088
[TBL] [Abstract][Full Text] [Related]
16. Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction.
Alcaide-Aldeano A; Garay A; Alcoberro L; Jiménez-Marrero S; Yun S; Tajes M; García-Romero E; Díez-López C; González-Costello J; Mateus-Porta G; Cainzos-Achirica M; Enjuanes C; Comín-Colet J; Moliner P
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32331365
[TBL] [Abstract][Full Text] [Related]
17. Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction.
Barandiarán Aizpurua A; Sanders-van Wijk S; Brunner-La Rocca HP; Henkens MTHM; Weerts J; Spanjers MHA; Knackstedt C; van Empel VPM
ESC Heart Fail; 2021 Apr; 8(2):1304-1313. PubMed ID: 33522131
[TBL] [Abstract][Full Text] [Related]
18. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
[TBL] [Abstract][Full Text] [Related]
19. Intravenous iron for acute and chronic heart failure with reduced ejection fraction (HFrEF) patients with iron deficiency: An updated systematic review and meta-analysis.
Awad AK; Abdelgalil MS; Gonnah AR; Mouffokes A; Ahmad U; Awad AK; Elbadawy MA; Roberts DH
Clin Med (Lond); 2024 May; 24(3):100211. PubMed ID: 38643833
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry.
von Haehling S; Gremmler U; Krumm M; Mibach F; Schön N; Taggeselle J; Dahm JB; Angermann CE
Clin Res Cardiol; 2017 Jun; 106(6):436-443. PubMed ID: 28229219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
